RECRUITING

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Description

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Conditions

NauseaPain
Talk to us

Related Conditions:

NauseaPain

Study Overview

On this page

Study Details

Study overview

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Condition
Nausea
Intervention / Treatment

-

Contacts and Locations

Hackensack

Antonia Oladipo, Hackensack, New Jersey, United States, 07601

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Healthy
  • * English speaking
  • * female volunteers undergoing medical abortion whether for voluntary interruption of pregnancy or missed abortion
  • * Gestational age \</= 70 days confirmed via ultrasound
  • * Access to a time keeping device
  • * Willingness to complete a telephone or in-clinic follow up
  • * chronic medical problems including but not limited to cardiac conditions, malignancy or organ damage
  • * Failed medical abortion resulting in surgical management
  • * Known intrauterine infection
  • * Known allergy to ondansetron or ibuprofen
  • * Subjects chronically receiving analgesic drugs
  • * Subjects unable to give consent
  • * Subjects taking medications that interact with ondansetron or ibuprofen

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Hackensack Meridian Health,

Melissa Figueroa, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

2025-07-19